Hydroxocobalamin analysis and pharmacokinetics

Clinical Toxicology

Volumn 35, Issue 4, 1997, Pages 409-411

  Osterloh, John D ^a   Hall, Alan H ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ROCKY MOUNTAIN POISON AND DRUG CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDOTE; CYANIDE; HYDROXOCOBALAMIN; SODIUM THIOSULFATE;

CYANIDE POISONING; DRUG DETERMINATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; PHARMACOKINETICS; SMOKING;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HALF-LIFE; HEMATINICS; HUMANS; HYDROXOCOBALAMIN; SMOKING;

EID: 0030852790     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563659709043375     Document Type: Letter

References (3)

1. Houeto P, Borron SW, Sandouk P, Imbert M, Levillain P, Baud FJ. Pharmacokinetics of hydroxocobalamin in smoke inhalation victims. J Toxicol Oin Toxicol 1996;34:397-404.
2. Forsyth JC, Mueller PD, Becker CE, et al. Hydroxocobalamin as a cyanide antidote: Safety, efficacy and pharmacokinetics in heavily smoking normal volunteers. J Toxicol Clin Toxicol 1993;31:277-294. (Pubitemid 23159971)
3. Houeto P, Buneaux F, Galliot-Guilley M, Baud FJ, Levillain P. Determination of hydroxocobalamin and cyanocobalamin by derivative spectrophotometry in cyanide poisoning. J Anal Toxicol 1994;18:154-158. (Pubitemid 24148280)